Forgotten implications of HPV positivity for the majority of females: A clinical perspective

Cytopathology

Volumn 13, Issue 5, 2002, Pages 263-266

  Tidy, John ^a,b  

^a Jessop Wing ^*

^b JESSOP HOSPITAL FOR WOMEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOPSY; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER SCREENING; CELL PROLIFERATION; COLPOSCOPY; CYTOLOGY; DYSKARYOSIS; EDITORIAL; HUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEXUALLY TRANSMITTED DISEASE; SQUAMOUS CELL; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; WART VIRUS; FEMALE; GENETICS; IN SITU HYBRIDIZATION; ISOLATION AND PURIFICATION; MASS SCREENING; METHODOLOGY; PAPILLOMA VIRUS; UNITED KINGDOM; UTERINE CERVIX TUMOR; VIRUS INFECTION;

VIRUS DNA;

CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; GREAT BRITAIN; HUMANS; IN SITU HYBRIDIZATION; MASS SCREENING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0036435519     PISSN: 09565507     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2303.2002.00425.x     Document Type: Editorial

References (13)

1. Cervical screening programme. Statistical Bulletin 2001/22. England: Department of Health, 2000-01.
2. Williams GH, Romanowski P, Morris L et al. Improved cervical smear assessment using antibodies against proteins that regulate DNA replication. Proc Natl Acad Sci U S A 1998; 95: 14932-7.
3. Cuzick J, Sasieni P, Davies P et al. A systematic review of the role of human papillomavirus testing within a cervical screening programme. Health Technol Assess 1999; 3: 14.
4. Hausen Z. Papillomaviruses causing cancer: Evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000; 92: 690-8.
5. Nanda K, McCory DC, Myers ER et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: A systematic review. Ann Int Med 2000; 132: 810-9.
6. Woodman CBJ, Collins S, Winter H et al. Natural history of cervical human papillomavirus infection in young women: A longitudinal cohort study. Lancet 2001; 357: 1831-6.
7. Collins S, Mazloomzahed S, Winter H et al. High incidence of cervical human papillomavirus infection in women during their first sexual relationship. Br J Obstet Gynaecol 2002; 109: 96-8.
8. Cuzick J, Beverley E, Ho L et al. HPV testing in primary screening of older women. Br J Cancer 1999; 81: 554-8.
9. Cuzick J, Szarewski A, Terry G et al. Human papillomavirus testing in primary cervical screening. Lancet 1995; 345: 1533-7.
10. Solomon D, Davey D, Kurman R et al. The 2001 Bethesda system. JAMA 2002; 287: 2114-9.
11. The Atypical Squamous Cells of Undetermined Significance/Low-Grade squamous Intraepithelial Lesions Triage Study (ALTS) Group. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: Baseline data from a randomized trial. J Natl Cancer Inst 2000; 92: 397-402.
12. Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: Baseline results from a randomized trial. J Natl Cancer Inst 2001; 93: 293-9.
13. Grimes DA, Schulz KF. Uses and abuses of screening tests. Lancet 2002; 359: 881-4.